nach oben

Erschienen in:

01.04.2015 | Review article

Efficacy of transcatheter aortic valve implantation in patients with aortic stenosis and reduced LVEF

A systematic review

verfasst von: X. Luo, Z. Zhao, H. Chai, C. Zhang, Y. Liao, Q. Li, Y. Peng, W. Liu, X. Ren, Q. Meng, C. Chen, M. Chen, Y. Feng, D. Huang

Erschienen in: Herz | Sonderheft 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Transcatheter aortic valve implantation (TAVI) is safe and effective for patients with aortic stenosis (AS) who have a high operative risk. However, there is still debate on the effect of TAVI in AS patients with reduced left ventricular ejection fraction (REF). The objective of the review is to clarify the efficacy of TAVI and the impact of REF on the 30-day and midterm mortality in these patients.

Methods

Studies on TAVI were searched in PubMed, Embase, and the Cochrane Library databases and were included in this review following predefined criteria. Data were extracted and pooled risk ratios (RR) were synthesized to explore the relationship between REF and 30-day plus midterm mortality.

Results

Twenty-eight studies comprising 14,099 patients were included in the analysis of the association of REF with the prognosis of patients after TAVI. An average increase in left ventricular ejection fraction of 8–10 % was observed among these patients after TAVI. REF was not related to the 30-day mortality [RR = 1.90, 95 % confidence interval (CI) = 0.80–4.47]; however, it was related to the midterm mortality (RR = 1.49, 95 %CI = 1.14–1.93) of patients undergoing TAVI. Patients with low-flow and low-gradient AS had a higher 30-day mortality (RR = 1.54, 95 %CI = 1.11–2.13) and midterm mortality rate (RR = 1.69, 95 %CI = 1.33–2.14) compared with AS patients without these characteristics. The mortality of TAVI patients was significantly lower than that of those undergoing conservative therapy, and was similar to that of patients undergoing surgical aortic valve replacement.

Conclusion

REF was not associated with 30-day mortality, but it was associated with the midterm mortality of TAVI patients. Patients with REF could benefit from TAVI compared with conservative therapy.

Nur mit Berechtigung zugänglich

Smith CR, Leon MB, Mack MJ et al (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364(23):2187–2198CrossRefPubMed

Leon MB, Smith CR, Mack M et al (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363(17):1597–1607CrossRefPubMed

Tamburino C, Capodanno D, Ramondo A et al (2011) Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 123(3):299–308CrossRefPubMed

Moat NE, Ludman P, Belder MA de et al (2011) Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) registry. J Am Coll Cardiol 58(20):2130–2138CrossRefPubMed

Toggweiler S, Humphries KH, Lee M et al (2013) 5-year outcome after transcatheter aortic valve implantation. J Am Coll Cardiol 61(4):413–419CrossRefPubMed

Zahn R, Gerckens U, Linke A et al (2013) Predictors of one-year mortality after transcatheter aortic valve implantation for severe symptomatic aortic stenosis. Am J Cardiol

Kodali SK, Williams MR, Smith CR et al (2012) Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 366(18):1686–1695CrossRefPubMed

Bleiziffer S, Mazzitelli D, Opitz A et al (2012) Beyond the short-term: clinical outcome and valve performance 2 years after transcatheter aortic valve implantation in 227 patients. J Thorac Cardiovasc Surg 143(2):310–317CrossRefPubMed

Codner P, Assali A, Dvir D et al (2013) Two-year outcomes for patients with severe symptomatic aortic stenosis treated with transcatheter aortic valve implantation. Am J Cardiol

10.

Hakki AH, Kimbiris D, Iskandrian AS et al (1980) Angina pectoris and coronary artery disease in patients with severe aortic valvular disease. Am Heart J 100(4):441–449CrossRefPubMed

11.

Ross J Jr, Braunwald E (1968) Aortic stenosis. Circulation 38(1 Suppl):61–67CrossRefPubMed

12.

Tribouilloy C, Levy F, Rusinaru D et al (2009) Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography. J Am Coll Cardiol 53(20):1865–1873CrossRefPubMed

13.

Nishimura RA, Grantham JA, Connolly HM et al (2002) Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation 106(7):809–813CrossRefPubMed

14.

Quere JP, Monin JL, Levy F et al (2006) Influence of preoperative left ventricular contractile reserve on postoperative ejection fraction in low-gradient aortic stenosis. Circulation 113(14):1738–1744CrossRefPubMed

15.

Pereira JJ, Lauer MS, Bashir M et al (2002) Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. J Am Coll Cardiol 39(8):1356–1363CrossRefPubMed

16.

Levy F, Laurent M, Monin JL et al (2008) Aortic valve replacement for low-flow/low-gradient aortic stenosis operative risk stratification and long-term outcome: a European multicenter study. J Am Coll Cardiol 51(15):1466–1472CrossRefPubMed

17.

Amabile N, Ramadan R, Ghostine S et al (2012) Early and mid-term cardiovascular outcomes following TAVI: Impact of pre-procedural transvalvular gradient. Int J Cardiol

18.

Hayashida K, Morice MC, Chevalier B et al (2012) Sex-related differences in clinical presentation and outcome of transcatheter aortic valve implantation for severe aortic stenosis. J Am Coll Cardiol 59(6):566–571CrossRefPubMed

19.

Houthuizen P, Van Garsse LA, Poels TT et al (2012) Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death. Circulation 126(6):720–728CrossRefPubMed

20.

Nombela-Franco L, Webb JG, Jaegere PP de et al (2012) Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation 126(25):3041–3053CrossRefPubMed

21.

Wenaweser P, Pilgrim T, Roth N et al (2011) Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. Am Heart J 161(6):1114–1124CrossRefPubMed

22.

Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283(15):2008–2012CrossRefPubMed

23.

Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097CrossRefPubMedCentralPubMed

24.

Elm E von, Altman DG, Egger M et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370(9596):1453–1457CrossRef

25.

Zhang J, Yu KF (1998) What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280(19):1690–1691CrossRefPubMed

26.

Seiffert M, Schnabel R, Conradi L et al (2012) Predictors and outcomes after transcatheter aortic valve implantation using different approaches according to the valve academic research consortium definitions. Catheter Cardiovasc Interv

27.

Amabile N, Azmoun A, Ghostine S et al (2012) Incidence, predictors and prognostic value of serious hemorrhagic complications following transcatheter aortic valve implantation. Int J Cardiol

28.

Elhmidi Y, Bleiziffer S, Piazza N et al (2013) The evolution and prognostic value of N-terminal brain natriuretic peptide in predicting 1-year mortality in patients following transcatheter aortic valve implantation. J Invasive Cardiol 25(1):38–44±30.32PubMed

29.

Lauten A, Zahn R, Horack M et al (2012) Transcatheter aortic valve implantation in patients with low-flow, low-gradient aortic stenosis. JACC Cardiovasc Interv 5(5):552–559CrossRefPubMed

30.

Sinning JM, Horack M, Grube E et al (2012) The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation: results from the German Transcatheter Aortic Valve Interventions Registry. Am Heart J 164(1):102–110 e101CrossRefPubMed

31.

Rodes-Cabau J, Webb JG, Cheung A et al (2010) Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 55(11):1080–1090CrossRefPubMed

32.

Stohr R, Dohmen G, Herpertz R et al (2011) Thirty-day outcome after transcatheter aortic valve implantation compared with surgical valve replacement in patients with high-risk aortic stenosis: a matched comparison. Coron Artery Dis 22(8):595–600CrossRefPubMed

33.

Meguro K, Lellouche N, Yamamoto M et al (2013) Prognostic value of QRS duration after transcatheter aortic valve implantation for aortic stenosis using the core valve. Am J Cardiol

34.

Stortecky S, Buellesfeld L, Wenaweser P et al (2013) Atrial fibrillation and aortic stenosis: impact on clinical outcomes among patients undergoing transcatheter aortic valve implantation. Circ Cardiovasc Interv 6(1):77–84CrossRefPubMed

35.

Wendler O, Walther T, Schroefel H et al (2013) Transapical aortic valve implantation: mid-term outcome from the SOURCE registry. Eur J Cardiothorac Surg 43(3):505–511 (discussion 511–502)CrossRefPubMed

36.

Pilgrim T, Wenaweser P, Meuli F et al (2011) Clinical outcome of high-risk patients with severe aortic stenosis and reduced left ventricular ejection fraction undergoing medical treatment or TAVI. PLoS One 6(11):e27556CrossRefPubMedCentralPubMed

37.

Munoz-Garcia AJ, Jimenez-Navarro MF, Rodriguez-Bailon I et al (2012) Impact of transcatheter aortic valve implantation with the CoreValve prosthesis in patients with severe aortic stenosis and left ventricular dysfunction. Int J Cardiol 157(1):124–125CrossRefPubMed

38.

Ewe SH, Ajmone Marsan N, Pepi M et al (2010) Impact of left ventricular systolic function on clinical and echocardiographic outcomes following transcatheter aortic valve implantation for severe aortic stenosis. Am Heart J 160(6):1113–1120CrossRefPubMed

39.

Gotzmann M, Rahlmann P, Hehnen T et al (2012) Heart failure in severe aortic valve stenosis: prognostic impact of left ventricular ejection fraction and mean gradient on outcome after transcatheter aortic valve implantation. Eur J Heart Fail 14(10):1155–1162CrossRefPubMed

40.

Fraccaro C, Al-Lamee R, Tarantini G et al (2012) Transcatheter aortic valve implantation in patients with severe left ventricular dysfunction: immediate and mid-term results, a multicenter study. Circ Cardiovasc Interv 5(2):253–260CrossRefPubMed

41.

Boon RM van der, Nuis RJ, Van Mieghem NM et al (2012) Clinical outcome following Transcatheter Aortic Valve Implantation in patients with impaired left ventricular systolic function. Catheter Cardiovasc Interv 79(5):702–710CrossRefPubMed

42.

Unbehaun A, Pasic M, Buz S et al (2012) Transapical aortic valve implantation in patients with severely depressed left ventricular function. J Thorac Cardiovasc Surg 143(6):1356–1363CrossRefPubMed

43.

Erez A, Segev A, Medvedofsky D et al (2014) Factors affecting survival in men versus women following transcatheter aortic valve implantation. Am J Cardiol 113(4):701–705CrossRefPubMed

44.

Barbanti M, Binder RK, Dvir D et al (2014) Prevalence and impact of preoperative moderate/severe tricuspid regurgitation on patients undergoing transcatheter aortic valve replacement. Catheter Cardiovasc Interv

45.

El-Mawardy M, Wubken-Kleinfeld N, Schwarz B et al (2014) Transcatheter aortic valve implantation in patients with severely reduced left ventricular systolic function: a single-center experience. Clin Res Cardiol 103(8):621–630CrossRefPubMed

46.

Elmariah S, Palacios IF, McAndrew T et al (2013) Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A). Circ Cardiovasc Interv 6(6):604–614CrossRefPubMed

47.

Barbash IM, Minha S, Ben-Dor I et al (2014) Relation of preprocedural assessment of myocardial contractility reserve on outcomes of aortic stenosis patients with impaired left ventricular function undergoing transcatheter aortic valve implantation. Am J Cardiol 113(9):1536–1542CrossRefPubMed

48.

Ben-Dor I, Maluenda G, Iyasu GD et al (2012) Comparison of outcome of higher versus lower transvalvular gradients in patients with severe aortic stenosis and low (< 40 %) left ventricular ejection fraction. Am J Cardiol 109(7):1031–1037CrossRefPubMed

49.

Clavel MA, Webb JG, Rodes-Cabau J et al (2010) Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction. Circulation 122(19):1928–1936CrossRefPubMed

50.

Bauer F, Coutant V, Bernard M et al (2013) Patients with severe aortic stenosis and reduced ejection fraction: earlier recovery of left ventricular systolic function after transcatheter aortic valve implantation compared with surgical valve replacement. Echocardiography

51.

Gotzmann M, Lindstaedt M, Bojara W et al (2012) Clinical outcome of transcatheter aortic valve implantation in patients with low-flow, low gradient aortic stenosis. Catheter Cardiovasc Interv 79(5):693–701CrossRefPubMed

52.

O’Sullivan CJ, Stortecky S, Heg D et al (2013) Clinical outcomes of patients with low-flow, low-gradient, severe aortic stenosis and either preserved or reduced ejection fraction undergoing transcatheter aortic valve implantation. Eur Heart J 34(44):3437–3450CrossRef

53.

Le Ven F, Freeman M, Webb J et al (2013) Impact of low flow on the outcome of high-risk patients undergoing transcatheter aortic valve replacement. J Am Coll Cardiol 62(9):782–788CrossRef

54.

Elhmidi Y, Piazza N, Krane M et al (2014) Clinical presentation and outcomes after transcatheter aortic valve implantation in patients with low flow/low gradient severe aortic stenosis. Catheter Cardiovasc Interv 84(2):283–290CrossRefPubMed

55.

Smith N, McAnulty JH, Rahimtoola SH (1978) Severe aortic stenosis with impaired left ventricular function and clinical heart failure: results of valve replacement. Circulation 58(2):255–264CrossRefPubMed

56.

Carabello BA, Green LH, Grossman W et al (1980) Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure. Circulation 62(1):42–48CrossRefPubMed

57.

Ross J Jr (1985) Afterload mismatch in aortic and mitral valve disease: implications for surgical therapy. J Am Coll Cardiol 5(4):811–826CrossRefPubMed

58.

Vaquette B, Corbineau H, Laurent M et al (2005) Valve replacement in patients with critical aortic stenosis and depressed left ventricular function: predictors of operative risk, left ventricular function recovery, and long term outcome. Heart 91(10):1324–1329CrossRefPubMedCentralPubMed

59.

Morris JJ, Schaff HV, Mullany CJ et al (1993) Determinants of survival and recovery of left ventricular function after aortic valve replacement. Ann Thorac Surg 56(1):22–29 (discussion 29–30)CrossRefPubMed

60.

Connolly HM, Oh JK, Schaff HV et al (2000) Severe aortic stenosis with low transvalvular gradient and severe left ventricular dysfunction:result of aortic valve replacement in 52 patients. Circulation 101(16):1940–1946CrossRefPubMed

61.

Powell DE, Tunick PA, Rosenzweig BP et al (2000) Aortic valve replacement in patients with aortic stenosis and severe left ventricular dysfunction. Arch Intern Med 160(9):1337–1341CrossRefPubMed

62.

Borz B, Durand E, Godin M et al (2012) Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis. Heart

63.

Monin JL, Quere JP, Monchi M et al (2003) Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 108(3):319–324CrossRefPubMed

Titel: Efficacy of transcatheter aortic valve implantation in patients with aortic stenosis and reduced LVEF
A systematic review
verfasst von: X. Luo
Z. Zhao
H. Chai
C. Zhang
Y. Liao
Q. Li
Y. Peng
W. Liu
X. Ren
Q. Meng
C. Chen
M. Chen
Y. Feng
D. Huang
Publikationsdatum: 01.04.2015
Verlag: Urban & Vogel
Erschienen in: Herz / Ausgabe Sonderheft 2/2015
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI: https://doi.org/10.1007/s00059-014-4193-z

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 2/2015

Outcome of cryoballoon ablation for atrial fibrillation

Bicuspid aortic valve endocarditis complicated by ruptured sinus of Valsalva aneurysm

Relevance of P-glycoprotein in stroke prevention with dabigatran, rivaroxaban, and apixaban

Mechanisms mediating renal sympathetic nerve activation in obesity-related hypertension